A novel 11 base pair deletion in KMT2C resulting in Kleefstra syndrome 2.
COMPASS complex disorder
KMT2C
Kleefstra syndrome 2
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
26 Dec 2023
26 Dec 2023
Historique:
revised:
07
12
2023
received:
05
10
2023
accepted:
11
12
2023
medline:
26
12
2023
pubmed:
26
12
2023
entrez:
26
12
2023
Statut:
aheadofprint
Résumé
Haploinsufficiency of the Lysine Methyltransferase 2C (KMT2C) gene results in the autosomal dominant disorder, Kleefstra syndrome 2. It is an extremely rare neurodevelopmental condition, with 14 previous reports describing varied clinical manifestations including dysmorphic features, delayed psychomotor development and delayed growth. Here, we describe a female with global developmental delay, attention deficit disorder, dyspraxia, short stature and subtle non-specific dysmorphic features. To identify causative mutations, whole exome sequencing was performed on the proband and her younger brother with discrete clinical presentation. Whole exome sequencing identified a novel de novo heterozygous 11 bp deletion in KMT2C (c.1759_1769del), resulting in a frameshift mutation and early termination of the protein (p.Gln587SerfsTer7). This variant is the second-most N-terminal reported mutation, located 4171 amino acids upstream of the critical enzymatically active SET domain (required for chromatin modification and histone methylation). The majority of the other reported mutations are frameshift mutations upstream of the SET domain and are predicted to result in protein truncation. It is thought that truncation of the SET domain, results functionally in an inability to modify chromatin through histone methylation. This report expands the clinical and genetic characterisation of Kleefstra syndrome 2.
Sections du résumé
BACKGROUND
BACKGROUND
Haploinsufficiency of the Lysine Methyltransferase 2C (KMT2C) gene results in the autosomal dominant disorder, Kleefstra syndrome 2. It is an extremely rare neurodevelopmental condition, with 14 previous reports describing varied clinical manifestations including dysmorphic features, delayed psychomotor development and delayed growth.
METHODS
METHODS
Here, we describe a female with global developmental delay, attention deficit disorder, dyspraxia, short stature and subtle non-specific dysmorphic features. To identify causative mutations, whole exome sequencing was performed on the proband and her younger brother with discrete clinical presentation.
RESULTS
RESULTS
Whole exome sequencing identified a novel de novo heterozygous 11 bp deletion in KMT2C (c.1759_1769del), resulting in a frameshift mutation and early termination of the protein (p.Gln587SerfsTer7). This variant is the second-most N-terminal reported mutation, located 4171 amino acids upstream of the critical enzymatically active SET domain (required for chromatin modification and histone methylation).
CONCLUSION
CONCLUSIONS
The majority of the other reported mutations are frameshift mutations upstream of the SET domain and are predicted to result in protein truncation. It is thought that truncation of the SET domain, results functionally in an inability to modify chromatin through histone methylation. This report expands the clinical and genetic characterisation of Kleefstra syndrome 2.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2350Subventions
Organisme : Kate Edger Educational Charitable Trust
Organisme : IHC Foundation
Organisme : Stevenson Foundation
Informations de copyright
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Références
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013). Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics, Chapter 7, Unit7.20. https://doi.org/10.1002/0471142905.HG0720S76
Alonso-Gonzalez, A., Calaza, M., Amigo, J., González-Peñas, J., Martínez-Regueiro, R., Fernández-Prieto, M., Parellada, M., Arango, C., Rodriguez-Fontenla, C., & Carracedo, A. (2021). Exploring the biological role of postzygotic and germinal de novo mutations in ASD. Scientific Reports, 11(1), 1-15. https://doi.org/10.1038/s41598-020-79412-w
Brauer, B., Merino-Veliz, N., Ahumada-Marchant, C., Arriagada, G., & Bustos, F. J. (2023). KMT2C knockout generates ASD-like behaviors in mice. Frontiers in Cell and Developmental Biology, 11, 1227723. https://doi.org/10.3389/fcell.2023.1227723
Brea-Fernández, A. J., Álvarez-Barona, M., Amigo, J., Tubío-Fungueiriño, M., Caamaño, P., Fernández-Prieto, M., Barros, F., de Rubeis, S., Buxbaum, J., & Carracedo, Á. (2022). Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability. European Journal of Human Genetics, 30(8), 938-945. https://doi.org/10.1038/s41431-022-01087-w
Brunet, T., Jech, R., Brugger, M., Kovacs, R., Alhaddad, B., Leszinski, G., Riedhammer, K. M., Westphal, D. S., Mahle, I., Mayerhanser, K., Skorvanek, M., Weber, S., Graf, E., Berutti, R., Necpál, J., Havránková, P., Pavelekova, P., Hempel, M., Kotzaeridou, U., … Wagner, M. (2021). De novo variants in neurodevelopmental disorders-Experiences from a tertiary care center. Clinical Genetics, 100(1), 14-28. https://doi.org/10.1111/CGE.13946
Cheema, H. A., Waheed, N., & Saeed, A. (2022). Kleefstra syndrome with severe sensory neural deafness and De novo novel mutation. Journal of the College of Physicians and Surgeons-Pakistan: JCPSP, 32(2), 236-238. https://doi.org/10.29271/JCPSP.2022.02.236
Chen, C., Liu, Y., Rappaport, A. R., Kitzing, T., Schultz, N., Zhao, Z., Shroff, A. S., Dickins, R. A., Vakoc, C. R., Bradner, J. E., Stock, W., LeBeau, M. M., Shannon, K. M., Kogan, S., Zuber, J., & Lowe, S. W. (2014). MLL3 is a Haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell, 25(5), 652-665. https://doi.org/10.1016/J.CCR.2014.03.016
Dawkins, J. B. N., Wang, J., Maniati, E., Heward, J. A., Koniali, L., Kocher, H. M., Martin, S. A., Chelala, C., Balkwill, F. R., Fitzgibbon, J., & Grose, R. P. (2016). Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma. Cancer Research, 76(16), 4861-4871. https://doi.org/10.1158/0008-5472.CAN-16-0481
De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., Kou, Y., Liu, L., Fromer, M., Walker, S., Singh, T., Klei, L., Kosmicki, J., Fu, S. C., Aleksic, B., Biscaldi, M., Bolton, P. F., Brownfeld, J. M., Cai, J., … Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515(7526), 209-215. https://doi.org/10.1038/nature13772
Eissenberg, J. C., & Shilatifard, A. (2010). Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Developmental Biology, 339(2), 240-249. https://doi.org/10.1016/j.ydbio.2009.08.017
Faundes, V., Newman, W. G., Bernardini, L., Canham, N., Clayton-Smith, J., Dallapiccola, B., Davies, S. J., Demos, M. K., Goldman, A., Gill, H., Horton, R., Kerr, B., Kumar, D., Lehman, A., McKee, S., Morton, J., Parker, M. J., Rankin, J., Robertson, L., … Banka, S. (2018). Histone lysine methylases and demethylases in the landscape of human developmental disorders. American Journal of Human Genetics, 102(1), 175-187. https://doi.org/10.1016/j.ajhg.2017.11.013
Frega, M., Selten, M., Mossink, B., Keller, J. M., Linda, K., Moerschen, R., Qu, J., Koerner, P., Jansen, S., Oudakker, A., Kleefstra, T., van Bokhoven, H., Zhou, H., Schubert, D., & Nadif Kasri, N. (2020). Distinct pathogenic genes causing intellectual disability and autism exhibit a common neuronal network hyperactivity phenotype. Cell Reports, 30(1), 173-186.e6. https://doi.org/10.1016/j.celrep.2019.12.002
Grantham, R. (1974). Amino acid difference formula to help explain protein evolution. Science, 185(4154), 862-864. https://doi.org/10.1126/science.185.4154.862
Guo, H., Wang, T., Wu, H., Long, M., Coe, B. P., Li, H., Xun, G., Ou, J., Chen, B., Duan, G., Bai, T., Zhao, N., Shen, Y., Li, Y., Wang, Y., Zhang, Y., Baker, C., Liu, Y., Pang, N., … Xia, K. (2018). Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Molecular Autism, 9(1), 1-12. https://doi.org/10.1186/S13229-018-0247-Z/TABLES/3
Hu, D., Gao, X., Morgan, M. A., Herz, H. M., Smith, E. R., & Shilatifard, A. (2013). The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Molecular and Cellular Biology, 33(23), 4745-4754. https://doi.org/10.1128/MCB.01181-13
Iossifov, I., Levy, D., Allen, J., Ye, K., Ronemus, M., Lee, Y. H., Yamrom, B., & Wigler, M. (2015). Low load for disruptive mutations in autism genes and their biased transmission. Proceedings of the National Academy of Sciences of the United States of America, 112(41), E5600-E5607. https://doi.org/10.1073/PNAS.1516376112/-/DCSUPPLEMENTAL/PNAS.1516376112.SD02.XLSX
Iossifov, I., O'Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., Smith, J. D., Paeper, B., Nickerson, D. A., Dea, J., Dong, S., Gonzalez, L. E., Mandell, J. D., Mane, S. M., Murtha, M. T., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515(7526), 216-221. https://doi.org/10.1038/nature13908
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., … MacArthur, D. G. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434-443. https://doi.org/10.1038/s41586-020-2308-7
Kim, D. H., Kim, J., & Lee, J. W. (2011). Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis. Molecular Endocrinology, 25(12), 2076-2083. https://doi.org/10.1210/ME.2011-1198
Kleefstra, T., Brunner, H. G., Amiel, J., Oudakker, A. R., Nillesen, W. M., Magee, A., Geneviève, D., Cormier-Daire, V., van Esch, H., Fryns, J.-P., Hamel, B. C. J., Sistermans, E. A., de Vries, B. B. A., & van Bokhoven, H. (2006). Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. American Journal of Human Genetics, 79(2), 370-377. https://doi.org/10.1086/505693
Kleefstra, T., Kramer, J. M., Neveling, K., Willemsen, M. H., Koemans, T. S., Vissers, L. E. L. M., Wissink-Lindhout, W., Fenckova, M., van den Akker, W. M. R., Kasri, N. N., Nillesen, W. M., Prescott, T., Clark, R. D., Devriendt, K., van Reeuwijk, J., de Brouwer, A. P. M., Gilissen, C., Zhou, H., Brunner, H. G., … van Bokhoven, H. (2012). Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. The American Journal of Human Genetics, 91(1), 73-82. https://doi.org/10.1016/j.ajhg.2012.05.003
Kleefstra, T., Van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V., Houge, G., Foulds, N., Van Dooren, M., Willemsen, M. H., Pfundt, R., Turner, A., Wilson, M., McGaughran, J., Rauch, A., Zenker, M., Adam, M. P., Innes, M., Davies, C., González-Meneses López, A., Casalone, R., … Brunner, H. G. (2009). Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. Journal of Medical Genetics, 46(9), 598-606. https://doi.org/10.1136/jmg.2008.062950
Koemans, T. S., Kleefstra, T., Chubak, M. C., Stone, M. H., Reijnders, M. R. F., de Munnik, S., Willemsen, M. H., Fenckova, M., Stumpel, C. T. R. M., Bok, L. A., Sifuentes Saenz, M., Byerly, K. A., Baughn, L. B., Stegmann, A. P. A., Pfundt, R., Zhou, H., van Bokhoven, H., Schenck, A., & Kramer, J. M. (2017). Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder. PLoS Genetics, 13(10), e1006864. https://doi.org/10.1371/journal.pgen.1006864
Krumm, N., Turner, T. N., Baker, C., Vives, L., Mohajeri, K., Witherspoon, K., Raja, A., Coe, B. P., Stessman, H. A., He, Z. X., Leal, S. M., Bernier, R., & Eichler, E. E. (2015). Excess of rare, inherited truncating mutations in autism. Nature Genetics, 47(6), 582-588. https://doi.org/10.1038/ng.3303
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J. B., Fombonne, E., & O'Roak, B. J. (2017). Exonic mosaic mutations contribute risk for autism Spectrum disorder. American Journal of Human Genetics, 101(3), 369-390. https://doi.org/10.1016/J.AJHG.2017.07.016/ATTACHMENT/C0F70E70-E5E5-41EE-AF53-06448B3E7F0A/MMC8.XLSX
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014). ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Research, 42, D980-D985. https://doi.org/10.1093/nar/gkt1113
Lavery, W. J., Barski, A., Wiley, S., Schorry, E. K., & Lindsley, A. W. (2020). KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: An emerging class of congenital regulopathies. Clinical Epigenetics, 12(1), 10. https://doi.org/10.1186/s13148-019-0802-2
Lee, J., Kim, D. H., Lee, S., Yang, Q. H., Dong, K. L., Lee, S. K., Roeder, R. G., & Lee, J. W. (2009). A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proceedings of the National Academy of Sciences of the United States of America, 106(21), 8513-8518. https://doi.org/10.1073/PNAS.0902873106
Lee, J., Saha, P. K., Yang, Q. H., Lee, S., Jung, Y. P., Suh, Y., Lee, S. K., Chan, L., Roeder, R. G., & Lee, J. W. (2008). Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proceedings of the National Academy of Sciences, 105(49), 19229-19234. https://doi.org/10.1073/PNAS.0810100105
Lee, S., Lee, D. K., Dou, Y., Lee, J., Lee, B., Kwak, E., Kong, Y. Y., Lee, S. K., Roeder, R. G., & Lee, J. W. (2006). Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proceedings of the National Academy of Sciences, 103(42), 15392-15397. https://doi.org/10.1073/PNAS.0607313103
Li, X., Yao, R., Chang, G., Li, Q., Song, C., Li, N., Ding, Y., Li, J., Chen, Y., Wang, Y., Huang, X., Shen, Y., Zhang, H., Wang, J., & Wang, X. (2022). Clinical profiles and genetic spectra of 814 Chinese children with short stature. The Journal of Clinical Endocrinology & Metabolism, 107(4), 972-985. https://doi.org/10.1210/CLINEM/DGAB863
Liu, S., Tian, M., He, F., Li, J., Xie, H., Liu, W., Zhang, Y., Zhang, R., Yi, M., Che, F., Ma, X., Zheng, Y., Deng, H., Wang, G., Chen, L., Sun, X., Xu, Y., Wang, J., Zang, Y., … Guan, J. S. (2019). Mutations in ASH1L confer susceptibility to Tourette syndrome. Molecular Psychiatry, 25(2), 476-490. https://doi.org/10.1038/s41380-019-0560-8
Mahfouz, N. A., Kizhakkedath, P., Ibrahim, A., El Naofal, M., Ramaswamy, S., Harilal, D., Qutub, Y., Uddin, M., Taylor, A., Alloub, Z., AlBanna, A., Abuhammour, W., Fathalla, B., & Tayoun, A. A. (2020). Utility of clinical exome sequencing in a complex Emirati pediatric cohort. Computational and Structural Biotechnology Journal, 18, 1020-1027. https://doi.org/10.1016/J.CSBJ.2020.04.013
Nagy, E., & Maquat, L. E. (1998). A rule for termination-codon position within intron-containing genes: When nonsense affects RNA abundance. Trends in Biochemical Sciences, 23(6), 198-199. https://doi.org/10.1016/S0968-0004(98)01208-0
Ng, P. C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31(13), 3812-3814.
O'Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., Turner, E. H., Stanaway, I. B., Vernot, B., Malig, M., Baker, C., Reilly, B., Akey, J. M., Borenstein, E., Rieder, M. J., … Eichler, E. E. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485(7397), 246-250. https://doi.org/10.1038/nature10989
Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R., & Siepel, A. (2010). Detection of nonneutral substitution rates on mammalian phylogenies. Genome Research, 20(1), 110. https://doi.org/10.1101/GR.097857.109
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., Walker, M. F., Ober, G. T., Teran, N. A., Song, Y., El-Fishawy, P., Murtha, R. C., Choi, M., Overton, J. D., Bjornson, R. D., … State, M. W. (2012). De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature, 485(7397), 237-241. https://doi.org/10.1038/nature10945
Satterstrom, F. K., Kosmicki, J. A., Wang, J., Breen, M. S., De Rubeis, S., An, J. Y., Peng, M., Collins, R., Grove, J., Klei, L., Stevens, C., Reichert, J., Mulhern, M. S., Artomov, M., Gerges, S., Sheppard, B., Xu, X., Bhaduri, A., Norman, U., … Buxbaum, J. D. (2020). Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell, 180(3), 568-584.e23. https://doi.org/10.1016/J.CELL.2019.12.036/ATTACHMENT/0B26ABC3-A77A-4F26-806F-109797AEC47E/MMC5.XLSX
Schoch, K., Tan, Q. K. G., Stong, N., Deak, K. L., McConkie-Rosell, A., McDonald, M. T., Goldstein, D. B., Jiang, Y. H., & Shashi, V. (2020). Alternative transcripts in variant interpretation: The potential for missed diagnoses and misdiagnoses. Genetics in Medicine, 22(7), 1269-1275. https://doi.org/10.1038/s41436-020-0781-x
Schubert, H. L., Blumenthal, R. M., & Cheng, X. (2003). Many paths to methyltransfer: A chronicle of convergence. Trends in Biochemical Sciences, 28(6), 329-335. https://doi.org/10.1016/S0968-0004(03)00090-2
Sedkov, Y., Cho, E., Petruk, S., Cherbas, L., Smith, S. T., Jones, R. S., Cherbas, P., Canaani, E., Jaynes, J. B., & Mazo, A. (2003). Methylation at lysine 4 of histone H3 in ecdysone-dependent development of drosophila. Nature, 426(6962), 78-83. https://doi.org/10.1038/nature02080
Siano, M. A., De Maggio, I., Petillo, R., Cocciadiferro, D., Agolini, E., Majolo, M., Novelli, A., Della Monica, M., & Piscopo, C. (2022). De novo mutation in KMT2C manifesting as Kleefstra syndrome 2: Case report and literature review. Pediatric Reports, 14(1), 131-139. https://doi.org/10.3390/PEDIATRIC14010019
Stewart, D. R., Huang, A., Faravelli, F., Anderlid, B. M., Medne, L., Ciprero, K., Kaur, M., Rossi, E., Tenconi, R., Nordenskjöld, M., Gripp, K. W., Nicholson, L., Meschino, W. S., Capua, E., Quarrell, O. W. J., Flint, J., Irons, M., Giampietro, P. F., Schowalter, D. B., … Krantz, I. D. (2004). Subtelomeric deletions of chromosome 9q: A novel microdeletion syndrome. American Journal of Medical Genetics, 128 A(4), 340-351. https://doi.org/10.1002/ajmg.a.30136
Wu, D., & Li, R. (2022). Case report: Long-term treatment and follow-up of Kleefstra Syndrome-2. Frontiers in Pediatrics, 10, 579. https://doi.org/10.3389/FPED.2022.881838/BIBTEX
Yuen, R. K. C., Merico, D., Bookman, M., Howe, J. L., Thiruvahindrapuram, B., Patel, R. V., Whitney, J., Deflaux, N., Bingham, J., Wang, Z., Pellecchia, G., Buchanan, J. A., Walker, S., Marshall, C. R., Uddin, M., Zarrei, M., Deneault, E., D'Abate, L., Chan, A. J. S., … Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20(4), 602-611. https://doi.org/10.1038/nn.4524
Zhou, X., Feliciano, P., Shu, C., Wang, T., Astrovskaya, I., Hall, J. B., Obiajulu, J. U., Wright, J. R., Murali, S. C., Xu, S. X., Brueggeman, L., Thomas, T. R., Marchenko, O., Fleisch, C., Barns, S. D., Snyder, L. A. G., Han, B., Chang, T. S., Turner, T. N., … Chung, W. K. (2022). Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nature Genetics, 54(9), 1305-1319. https://doi.org/10.1038/S41588-022-01148-2